Effects of Perioperative B&O Suppositories on Post-op Pain and Morphine Use After Laparoscopic Prostatectomy
Completed · Not applicable
Conditions studied: Pain
In brief
This study is evaluating the effect of a Belladonna and Opium suppository administered intraoperatively on post operative pain after laparoscopic radical prostatectomy for prostate cancer. This is a blinded randomized study. 50% of patients will receive the suppository, 50% of patients will not. Neither you or your surgeon will know which group you are in.
Key facts
- Study ID
- NCT00863928
- Run by
- Benaroya Research Institute
- People needed
- 135
- Starts
- 2008-10-01
- Expected to finish
- 2009-07-01
- Last updated by the study team
- 2019-04-23
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Patients scheduled for laparoscopic radical prostatectomy at Virginia Mason, who do not have chronic pain or allergies to opioid analgesics are eligible for this study.
You may not qualify if…
- Women are excluded due to the absence of a prostate.
- Children are excluded due to the absence of prostate cancer in this group.
- Patients meeting any of the following will not be eligible for the study:
- Patients at risk for complications from anticholinergic agents including those with a history of glaucoma, bronchial asthma, convulsive disorder, or high risk for delirium
- History of previous allergies or adverse reactions to belladonna and opium and/or opioid analgesics
- History of chronic pain or chronic use of opioid and nonopioid analgesics
- History of alcohol or opioid dependency/abuse within last three months
Where it is running
- Virginia Mason Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.